{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,16]],"date-time":"2026-06-16T11:55:59Z","timestamp":1781610959713,"version":"3.54.5"},"reference-count":21,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,10,2]],"date-time":"2025-10-02T00:00:00Z","timestamp":1759363200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,10,2]],"date-time":"2025-10-02T00:00:00Z","timestamp":1759363200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Orphanet J Rare Dis"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Objective<\/jats:title>\n                    <jats:p>To evaluate the clinical outcomes of liver transplantation (LT) in patients with Caroli syndrome.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>We retrospectively analyzed clinical data from 20 patients diagnosed with Caroli syndrome who underwent LT at Beijing Friendship Hospital, Capital Medical University, between April 2014 and May 2024. Data included baseline characteristics, surgical parameters, complications, and survival. Follow-up concluded in February 2025.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      These 20 cases accounted for 1.23% (20\/1623) of all LTs during the study period. Thirteen patients received living donor liver transplants (LDLT), and seven received deceased donor liver transplants (DDLT). The cohort included 15 males and 5 females, aged 3\u201356 years (median 23.3). Common preoperative conditions included cirrhosis (\n                      <jats:italic>n<\/jats:italic>\n                      \u2009=\u200918), portal hypertension (\n                      <jats:italic>n<\/jats:italic>\n                      \u2009=\u200917), polycystic kidney disease (\n                      <jats:italic>n<\/jats:italic>\n                      \u2009=\u200916), and splenomegaly (\n                      <jats:italic>n<\/jats:italic>\n                      \u2009=\u200917). The median APACHE II score was 14; the predicted mortality averaged 26.0%. The median interval from the first major complication (e.g., recurrent cholangitis or decompensation) to LT was 12 months (IQR 4.5\u201321). No patients underwent cross-match or auxiliary LT; three had concurrent partial splenectomy. Postoperative complications included abdominal hemorrhage (\n                      <jats:italic>n<\/jats:italic>\n                      \u2009=\u20093) and seizures (\n                      <jats:italic>n<\/jats:italic>\n                      \u2009=\u20091). Chronic renal failure occurred in six patients during follow-up, and four experienced acute rejection (three recurrent). Compared with adults, pediatric patients had a higher proportion of females (\n                      <jats:italic>p<\/jats:italic>\n                      \u2009=\u20090.001), while chronic renal failure was more common in adults preoperatively (\n                      <jats:italic>p<\/jats:italic>\n                      \u2009=\u20090.010). Four patients (20%) died: one from heart failure (day 8), one from sudden death (6 months), one from pulmonary infection (1 year), and one from unknown causes (5.2 years). Median follow-up was 74.6 months (range 7-125). One-, three-, and five-year survival rates were 90%, 85%, and 78.5%, respectively.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>Liver transplantation significantly improves the survival prognosis for patients with Caroli syndrome, but attention to kidney function preservation and individualized immunosuppressive management is critical for optimal outcomes.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s13023-025-03943-6","type":"journal-article","created":{"date-parts":[[2025,10,2]],"date-time":"2025-10-02T12:35:14Z","timestamp":1759408514000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Clinical outcomes of liver transplantation in Caroli syndrome: a retrospective analysis"],"prefix":"10.1186","volume":"20","author":[{"given":"Fei","family":"Hou","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hao-Feng","family":"Xiong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ying","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shuang","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yi-Zhi","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qian","family":"Kang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jing-Yi","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lin","family":"Wei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei","family":"Qu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhi-Gui","family":"Zeng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhi-Jun","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1101-7994","authenticated-orcid":false,"given":"Li-Ying","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,10,2]]},"reference":[{"key":"3943_CR1","doi-asserted-by":"publisher","unstructured":"Uchida H, Inui A, Okamoto T, Yasui T, Honda M, Mizuta K et al. Optimal transplant strategy of pediatric liver transplantation for fibropolycystic liver disease: multicenter retrospective study in Japan. Hepatol Res 2024 Oct 15. https:\/\/doi.org\/10.1111\/hepr.14122. Online ahead of print.","DOI":"10.1111\/hepr.14122"},{"issue":"5","key":"3943_CR2","doi-asserted-by":"publisher","first-page":"381","DOI":"10.1111\/j.1432-2277.2006.00292.x","volume":"19","author":"L De Kerckhove","year":"2006","unstructured":"De Kerckhove L, De Meyer M, Verbaandert C, Mourad M, Sokal E, Goffette P, et al. The place of liver transplantation in caroli\u2019s disease and syndrome. Transpl Int. 2006;19(5):381\u20138.","journal-title":"Transpl Int"},{"issue":"1","key":"3943_CR3","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1111\/ctr.12640","volume":"30","author":"Q Lai","year":"2016","unstructured":"Lai Q, Lerut J. Proposal for an algorithm for liver transplantation in Caroli\u2019s disease and syndrome: putting an uncommon effort into a common task. Clin Transpl. 2016;30(1):3\u20139.","journal-title":"Clin Transpl"},{"key":"3943_CR4","doi-asserted-by":"publisher","first-page":"954","DOI":"10.1016\/j.hpb.2023.04.013","volume":"25","author":"G Orozco","year":"2023","unstructured":"Orozco G, Shah MB, Gupta M, Marti F, Mei X, Ancheta A, et al. Liver transplantation for biliary cysts: perioperative and long-term outcomes. HPB (Oxford). 2023;25:954\u201361.","journal-title":"HPB (Oxford)"},{"key":"3943_CR5","first-page":"003794","volume":"10","author":"F Cale\u00e7a Emidio","year":"2023","unstructured":"Cale\u00e7a Emidio F, Costa Pereira R, Blanco R, Santos P, Abeg\u00e3o T, Fitas C. An 84-year-old patient with caroli syndrome: what is the prognosis of this condition? Eur J Case Rep Intern Med. 2023;10:003794.","journal-title":"Eur J Case Rep Intern Med"},{"key":"3943_CR6","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1186\/s13256-023-03919-9","volume":"17","author":"A Ghassa","year":"2023","unstructured":"Ghassa A, Khouri L. Caroli syndrome associated with atrial septal defect and polydactyly: a case report. J Med Case Rep. 2023;17:213.","journal-title":"J Med Case Rep"},{"key":"3943_CR7","doi-asserted-by":"publisher","first-page":"682","DOI":"10.21037\/tp-23-574","volume":"13","author":"L Liu","year":"2024","unstructured":"Liu L, Huang Y, Fang F, Zhou H, Liu X. A case report of intrahepatic bile duct dilatation caused by WDR19 gene mutation and presented as caroli syndrome. Transl Pediatr. 2024;13:682\u20139.","journal-title":"Transl Pediatr"},{"key":"3943_CR8","doi-asserted-by":"publisher","first-page":"317","DOI":"10.1186\/s12876-020-01442-5","volume":"20","author":"W Shi","year":"2020","unstructured":"Shi W, Huang XM, Feng YL, Wang FD, Gao XX, Jiao Y. Factors contributing to diagnostic delay of Caroli syndrome: a single-center, retrospective study. BMC Gastroenterol. 2020;20:317.","journal-title":"BMC Gastroenterol"},{"key":"3943_CR9","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1016\/j.jviscsurg.2018.06.001","volume":"156","author":"R Fahrner","year":"2019","unstructured":"Fahrner R, Dennler SGC, Dondorf F, Ardelt M, Rauchfuss F, Settmacher U. Liver resection and transplantation in Caroli disease and syndrome. J Visc Surg. 2019;156:91\u20135.","journal-title":"J Visc Surg"},{"issue":"2","key":"3943_CR10","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1016\/j.radcr.2018.11.006","volume":"14","author":"A Rivas","year":"2019","unstructured":"Rivas A, Epelman M, Danzer E, Adzick NS, Victoria T. Prenatal MR imaging features of Caroli syndrome in association with autosomal recessive polycystic kidney disease. Radiol Case Rep. 2019;14(2):265\u20138.","journal-title":"Radiol Case Rep"},{"key":"3943_CR11","doi-asserted-by":"publisher","first-page":"497","DOI":"10.1038\/ajg.2014.253","volume":"110","author":"G Perricone","year":"2015","unstructured":"Perricone G. Image of the month: Caroli syndrome: central Dot sign on CT. Am J Gastroenterol. 2015;110:497.","journal-title":"Am J Gastroenterol"},{"key":"3943_CR12","doi-asserted-by":"publisher","first-page":"234","DOI":"10.1111\/jgh.12828","volume":"30","author":"G Perricone","year":"2015","unstructured":"Perricone G, Vanzulli A. Education and imaging. Hepatology: central Dot sign of Caroli syndrome. J Gastroenterol Hepatol. 2015;30:234.","journal-title":"J Gastroenterol Hepatol"},{"key":"3943_CR13","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1016\/j.ajg.2022.10.003","volume":"23","author":"M Yaghi","year":"2022","unstructured":"Yaghi M, Jaafar R, Kanso M, Khalife M, Faraj W. Choledochal anomalies in adults: A 20-year single-center retrospective cohort experience in the middle East. Arab J Gastroenterol. 2022;23:235\u201340.","journal-title":"Arab J Gastroenterol"},{"key":"3943_CR14","doi-asserted-by":"publisher","first-page":"26","DOI":"10.21037\/tgh-2020-04","volume":"6","author":"A Lasagni","year":"2021","unstructured":"Lasagni A, Cadamuro M, Morana G, Fabris L, Strazzabosco M. Fibrocystic liver disease: novel concepts and translational perspectives. Transl Gastroenterol Hepatol. 2021;6:26.","journal-title":"Transl Gastroenterol Hepatol"},{"key":"3943_CR15","doi-asserted-by":"publisher","first-page":"4718","DOI":"10.3748\/wjg.v26.i31.4718","volume":"26","author":"R Fahrner","year":"2020","unstructured":"Fahrner R, Dennler SG, Inderbitzin D. Risk of malignancy in Caroli disease and syndrome: A systematic review. World J Gastroenterol. 2020;26:4718\u201328.","journal-title":"World J Gastroenterol"},{"key":"3943_CR16","doi-asserted-by":"publisher","first-page":"1039","DOI":"10.1097\/LVT.0000000000000375","volume":"30","author":"LCY Tang","year":"2024","unstructured":"Tang LCY, Chetwood JD, Lai MSM, Yip TCF, Cao R, Powter E, et al. Incidence, epidemiology, and outcomes of acute allograft rejection following liver transplantation in Australia. Liver Transpl. 2024;30:1039\u201349.","journal-title":"Liver Transpl"},{"key":"3943_CR17","doi-asserted-by":"publisher","first-page":"210","DOI":"10.1016\/j.jhep.2013.09.020","volume":"60","author":"M Carbone","year":"2014","unstructured":"Carbone M, Neuberger JM. Autoimmune liver disease, autoimmunity and liver transplantation. J Hepatol. 2014;60:210\u201323.","journal-title":"J Hepatol"},{"key":"3943_CR18","doi-asserted-by":"publisher","first-page":"675","DOI":"10.1016\/j.jhep.2012.04.015","volume":"57","author":"R Adam","year":"2012","unstructured":"Adam R, Karam V, Delvart V, O\u2019Grady J, Mirza D, Klempnauer J, et al. Evolution of indications and results of liver transplantation in europe. A report from the europe.n liver transplant registry (ELTR). J Hepatol. 2012;57:675\u201388.","journal-title":"J Hepatol"},{"key":"3943_CR19","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1002\/lt.21394","volume":"14","author":"J Alexander","year":"2008","unstructured":"Alexander J, Lord JD, Yeh MM, Cuevas C, Bakthavatsalam R, Kowdley KV. Risk factors for recurrence of primary sclerosing cholangitis after liver transplantation. Liver Transpl. 2008;14:245\u201351.","journal-title":"Liver Transpl"},{"key":"3943_CR20","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3748\/wjg.v18.i1.1","volume":"18","author":"B Fosby","year":"2012","unstructured":"Fosby B, Karlsen TH, Melum E. Recurrence and rejection in liver transplantation for primary sclerosing cholangitis. World J Gastroenterol. 2012;18:1\u201315.","journal-title":"World J Gastroenterol"},{"issue":"2","key":"3943_CR21","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1111\/j.1399-0012.2005.00471.x","volume":"20","author":"DA Jacob","year":"2006","unstructured":"Jacob DA, Neumann UP, Bahra M, et al. Long-term follow-up after recurrence of primary biliary cirrhosis after liver transplantation in 100 patients. Clin Transpl. 2006;20(2):211\u201320.","journal-title":"Clin Transpl"}],"container-title":["Orphanet Journal of Rare Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13023-025-03943-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13023-025-03943-6","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13023-025-03943-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,16]],"date-time":"2026-06-16T11:36:42Z","timestamp":1781609802000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s13023-025-03943-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10,2]]},"references-count":21,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["3943"],"URL":"https:\/\/doi.org\/10.1186\/s13023-025-03943-6","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-6205735\/v1","asserted-by":"object"}]},"ISSN":["1750-1172"],"issn-type":[{"value":"1750-1172","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,10,2]]},"assertion":[{"value":"11 March 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 July 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 October 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This retrospective study utilized anonymized patient data and was approved by the Beijing Friendship Hospital Ethics Committee with a waiver of informed consent (Approval Number: 20241201). All procedures complied with the ethical standards of China and the principles of the Declaration of Helsinki.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval and consent to participate"}},{"value":"Not applicable. This study did not include any identifiable personal data, images, or videos.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests, financial or non-financial.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"497"}}